Clinic for Radiology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Radiol Oncol. 2012 Mar;46(1):19-22. doi: 10.2478/v10019-012-0004-4. Epub 2012 Jan 2.
The purpose of this retrospective study was to compare the results and complication rate in CT guided percutaneous trans-thoracic fine needle aspiration biopsies (FNAB) and core biopsies of lung lesions, and to determine the applicability of these needles.
In 242 patients (166 males; 76 females) with mean age of 58.9 years (13-84 years) CT guided biopsies of lung lesions were performed on dual slice CT equipment. The average diameter of lung lesion was 2.9 cm (1.2-6.3 cm). For FNAB's 20 - 22 G Chiba needles and for core biopsies 14 G biopsy needles were used. The samples were sent for the histological analysis. The cytological or histological results and the eventual complications were compared.
FNAB's cytological samples were adequate for definitive diagnosis in 117 patients (79.60 %) and inadequate in 30 patients (20.40 %). Core biopsies samples were adequate in 92 (96.85 %) patients and non- representative (necrotic tissue) in 3 (3.15 %). Pneumothorax as the most frequent complication was detected in 14 (9.7 %) of the patients in the group of FNAB's and in 30 (31.5 %) of the patients with the core biopsy group.
The results showed that percutaneous transthoracic CT guided biopsies of lung lesions were an effective and safe procedure in the diagnosis of lung lesions. Core biopsy gives a higher percentage of representative samples than FNAB, and is a preferred method regardless of the higher rate of complications.
本回顾性研究旨在比较 CT 引导经皮肺穿刺细针抽吸活检(FNAB)和肺病变核心活检的结果和并发症发生率,并确定这些针的适用性。
在 242 名患者(166 名男性;76 名女性)中,平均年龄为 58.9 岁(13-84 岁),在双源 CT 设备上进行 CT 引导肺病变活检。肺病变的平均直径为 2.9cm(1.2-6.3cm)。对于 FNAB,使用 20-22G Chiba 针,对于核心活检,使用 14G 活检针。将样本送检进行组织学分析。比较细胞学或组织学结果和最终并发症。
FNAB 的细胞学样本在 117 名患者(79.60%)中足以明确诊断,在 30 名患者(20.40%)中不足。核心活检样本在 92 名患者(96.85%)中足够,在 3 名患者(3.15%)中无代表性(坏死组织)。FNAB 组中 14 名(9.7%)患者和核心活检组中 30 名(31.5%)患者出现气胸作为最常见的并发症。
结果表明,CT 引导经皮肺穿刺活检是诊断肺病变的一种有效且安全的方法。核心活检比 FNAB 提供更高比例的代表性样本,并且是一种首选方法,尽管并发症发生率较高。